SCHEMBL23309562

SCHEMBL23309562

O=C(Nc1ccc(Oc2ccccc2)cc1)c1cc(F)nc(F)c1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PNLIP P16233 1/20 0.56
▸ PGR P06401 2/20 0.54
▸ KMT2A Q03164 4/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ HPGD P15428 2/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ GAA P10253 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ KDR P35968 1/20 0.52
▸ STK39 Q9UEW8 1/20 0.51
▸ MAPK1 P28482 1/20 0.50
▸ GFER P55789 1/20 0.50
▸ TLR8 Q9NR97 1/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ LMNA P02545 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ HTT P42858 2/20 0.49
▸ USP2 O75604 1/20 0.49
▸ POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309585 0.90 KDM4E (0.52) KMT2AMEN1L3MBTL1HPGDNPC1
SCHEMBL23309490 0.88 GAA (0.51) KMT2AMEN1L3MBTL1HPGDNPC1
SCHEMBL23309730 0.86 KMT2A (0.47) KMT2AMEN1NPC1GAARAB9A
SCHEMBL23309617 0.84 NPC1 (0.54) PNLIPKMT2AMEN1NPC1GAA
SCHEMBL23309645 0.82 ALDH1A1 (0.51) PNLIPKMT2AMEN1NPC1GAA
SCHEMBL23309707 0.82 ABL1 (0.54) KMT2AMEN1L3MBTL1NPC1RAB9A
SCHEMBL23309584 0.81 NPC1 (0.57) KMT2AMEN1NPC1GAARAB9A
SCHEMBL23309528 0.81 PRSS12 (0.44) KMT2AMEN1NPC1GAARAB9A
SCHEMBL23309708 0.80 RAB9A (0.52) KMT2ANPC1GAARAB9AMAPK1
SCHEMBL23309621 0.80 RAB9A (0.50) KMT2AMEN1HPGDNPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL PNLIP 1145/4885PGR 3767/4885KMT2A 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback